Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Influenza Diagnostic Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The influenza diagnostic market size has experienced robust growth over recent years. It is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, with a compound annual growth rate (CAGR) of 8.3%. This historical growth can be ascribed to elements such as seasonal influenza outbreaks, the prevalent use of rapid antigen tests, the development of hospital laboratory infrastructure, government influenza surveillance programs, and heightened awareness of early flu diagnosis.
The influenza diagnostic market size is anticipated to experience substantial expansion over the next few years, reaching $4.19 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.8%. This projected growth stems from several factors, including the increasing occurrence of influenza epidemics, a rising requirement for precise molecular diagnostics, the broadening of point-of-care testing infrastructure, enhanced public health readiness programs, and advancements in rapid diagnostic assays. Significant trends expected during this period encompass a surging demand for swift influenza testing, greater adoption of molecular diagnostic techniques, an increasing preference for point-of-care flu diagnostics, the expansion of seasonal and pandemic surveillance testing, and continuous improvements in the sensitivity and specificity of tests.
Get A Free Sample Report With In-Depth Market Insights:
Influenza Diagnostic Market Demand Drivers Opening New Revenue Streams
Increased investment in research on influenza diagnostics is anticipated to stimulate the expansion of the influenza diagnostic market moving forward. Funding for research on influenza diagnostics involves financial resources provided by government agencies, institutions, and various organizations to back scientific investigations aimed at developing, improving, and verifying methods and technologies for identifying influenza viruses. The rise in funding for influenza research is largely influenced by lessons from the COVID-19 pandemic and concerns regarding future respiratory disease outbreaks, as health authorities acknowledge the critical necessity of rapid and accurate diagnostic capabilities to avert widespread transmission and enable prompt public health interventions. Augmented research funding facilitates the advancement and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and enhanced laboratory procedures that allow for faster and more precise identification of influenza strains in clinical settings. For example, in October 2024, as per the Department of Health and Aged Care, an Australia-based government organization responsible for health research, funding, promotion, and regulation, the Australian Government is allocating $95 million to combat avian influenza, thereby protecting agriculture, wildlife, and the economy. Therefore, greater funding for research in influenza diagnostics is fueling the growth of the influenza diagnostic market.
Influenza Diagnostic Market Segment Landscape And Growth Outlook
The influenza diagnostic market covered in this report is segmented –
1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays
Influenza Diagnostic Market Trends Powering Strategic Industry Growth
Leading firms within the influenza diagnostic market are creating advanced solutions, including the Lucira COVID-19 & Flu Home Test, designed for concurrent, rapid qualitative detection. This Lucira COVID-19 and Flu Home Test functions as a disposable, at-home kit, delivering results from user-collected nasal swab samples in approximately 30 minutes. As an illustration, during February 2023, Pfizer Inc., a pharmaceutical company based in the US, secured approval for its Lucira COVID-19 & Flu Home Test. The test is capable of identifying influenza A and B, widely recognized as the flu, along with SARS-CoV-2, the pathogen responsible for COVID-19.
Influenza Diagnostic Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.
View The Full Influenza Diagnostic Market Report:
Influenza Diagnostic Market Geographic Spread And Regional Opportunities
North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
